Clinical Development
Powerful Data and Technology for Successful Trials
Optimize clinical trials and reduce patient burden with technology integrated with the largest real-world oncology datasets in the industry for faster patient eligibility and feasibility assessments.
Large, Independent, Deep Datasets
AI-Derived Variables for Scale and Validity
Linkages to Claims Data
Integration with 1st and 3rd Party Data
STUDY DESIGN
Rapid Exploration of Large-Scale RWD
Easily filter and find key patient, disease, and treatment characteristics
![Study Design Funnel](https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Study%20Design%20Funnel.png)
![Study Design Stage](https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Study%20Design%20Stage.png)
![Study Design Nsclc](https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Study%20Design%20Nsclc.png)
![Study Design Stage](https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Study%20Design%20Stage%202.png)
![Study Design Line Of Therapy](https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Study%20Design%20Line%20Of%20Therapy.png)
![Study Design Ecog](https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Study%20Design%20Ecog.png)
STUDY DESIGN
The ability to design higher quality studies at the earliest
phases of the clinical development process can lead to:
Time Savings
Cost Savings
Faster Time to Market
23 %
Reduced time for study design